R&D

News

UK's long-term R&D investment policy welcomed

The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.

News

Sanofi pledges a $20 billion investment programme in the US

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US.

R&D

Q1 Clinical trials round-up: Jan-Mar 2025

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.

News

Gilead Sciences' chief executive Daniel O'Day

Gilead ups its US investment plans by $11 billion

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US.

News

EU joins the bid to court beleaguered US scientists

The EU has announced a €500m scheme to convince scientific talent from around the world to relocate to Europe's "free and open" research environment.

News

Can other countries entice US scientists hit by Trump cuts?

The UK is said to be preparing a £50m scheme to attract top scientific talent from other countries, including US teams facing big funding cuts.

UK's long-term R&D investment policy welcomed

Sanofi pledges a $20 billion investment programme in the US

Q1 Clinical trials round-up: Jan-Mar 2025

Gilead ups its US investment plans by $11 billion

EU joins the bid to court beleaguered US scientists

Can other countries entice US scientists hit by Trump cuts?

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks